Page 132 - 《中国药房》2024年15期

The effect of metformin on chemotherapy-induced toxici‐ diet with or without metformin in patients with advanced
ties in non-diabetic breast cancer patients：a randomised non-small cell lung cancer[J]. Lung Cancer，2021，151：
controlled study[J]. Drug Saf，2023，46（6）：587-599. 8-15.
[37] YANG J J，ZHOU Y L，XIE S D，et al. Metformin induces [47] WANG Z G，LU C H，ZHANG K J，et al. Metformin com‐
ferroptosis by inhibiting UFMylation of SLC7A11 in bining PD-1 inhibitor enhanced anti-tumor efficacy in
breast cancer[J]. J Exp Clin Cancer Res，2021，40（1）：206. STK11 mutant lung cancer through AXIN-1-dependent in‐
[38] KIM H M，KANG M J，SONG S O. Metformin and cervi‐ hibition of STING ubiquitination[J]. Front Mol Biosci，
cal cancer risk in patients with newly diagnosed type 2 2022，9：780200.
diabetes：a population-based study in Korea[J]. Endocrinol [48] ZHAO Y W，LUO Q M，MO J R，et al. Metformin in com‐
Metab （Seoul），2022，37（6）：929-937. bination with JS-K inhibits growth of renal cell carcinoma
[39] CHEN Y H，YANG S F，YANG C K，et al. Metformin in‐ cells via reactive oxygen species activation and inducing
duces apoptosis and inhibits migration by activating the DNA breaks[J]. J Cancer，2020，11（13）：3701-3712.
AMPK/p53 axis and suppressing PI3K/AKT signaling in [49] HAMIEH L，MCKAY R R，LIN X，et al. Effect of metfor‐
human cervical cancer cells[J]. Mol Med Rep，2021， min use on survival outcomes in patients with metastatic
23（1）：88. renal cell carcinoma[J]. Clin Genitourin Cancer，2017，15
[40] XIA C L，LIU C，HE Z H，et al. Metformin inhibits cervi‐ （2）：221-229.
cal cancer cell proliferation by modulating PI3K/Akt- [50] LIU M H，ZHANG Z，WANG H，et al. Activation of
induced major histocompatibility complex class Ⅰ-related AMPK by metformin promotes renal cancer cell prolifera‐
chain A gene expression[J]. J Exp Clin Cancer Res，2020， tion under glucose deprivation through its interaction with
39（1）：127. PKM2[J]. Int J Biol Sci，2019，15（3）：617-627.
[41] LU T，LI M，ZHAO M N，et al. Metformin inhibits human [51] GE L，WU Y G，WAN M，et al. Metformin increases sensi‐
non-small cell lung cancer by regulating AMPK-CEBPB- tivity of melanoma cells to cisplatin by blocking
PDL1 signaling pathway[J]. Cancer Immunol Immuno‐ exosomal-mediated miR-34a secretion[J]. J Oncol，2021，
ther，2022，71（7）：1733-1746. 2021：5525231.
[42] ZHU Z L，JIANG T，SUO H R，et al. Metformin poten- [52] MONTAUDIÉ H，CEREZO M，BAHADORAN P，et al.
tiates the effects of anlotinib in NSCLC via AMPK/mTOR Metformin monotherapy in melanoma：a pilot，open-label，
and ROS-mediated signaling pathways[J]. Front Pharma‐ prospective，and multicentric study indicates no benefit[J].
col，2021，12：712181. Pigment Cell Melanoma Res，2017，30（3）：378-380.
[43] ZHANG Q M，ZHENG J，WANG W，et al. The anticancer [53] AFZAL M Z，MERCADO R R，SHIRAI K. Efficacy of
effect of metformin combined with epidermal growth fac‐ metformin in combination with immune checkpoint inhibi‐
tor receptor tyrosine kinase inhibitors in non-small cell tors （anti-PD-1/anti-CTLA-4） in metastatic malignant
lung cancer patients with or without type 2 diabetes melli‐ melanoma[J]. J Immunother Cancer，2018，6（1）：64.
tus：a systematic review and meta-analysis[J]. Oncol Ther， [54] CICCARESE C，IACOVELLI R，BUTI S，et al. Concur‐
2022，10（2）：363-375. rent nivolumab and metformin in diabetic cancer patients：
[44] TSAKIRIDIS T，POND G R，WRIGHT J，et al. Metfor‐ is it safe and more active? [J]. Anticancer Res，2022，42
min in combination with chemoradiotherapy in locally ad‐ （3）：1487-1493.
vanced non-small cell lung cancer：the OCOG-ALMERA [55] ZHUANG A，CHAI P W，WANG S Y，et al. Metformin
randomized clinical trial[J]. JAMA Oncol，2021，7（9）： promotes histone deacetylation of optineurin and sup‐
1333-1341. presses tumour growth through autophagy inhibition in
[45] SKINNER H，HU C，TSAKIRIDIS T，et al. Addition of ocular melanoma[J]. Clin Transl Med，2022，12（1）：e660.
metformin to concurrent chemoradiation in patients with [56] ABDELMONEIM M，ABOALELA M A，NAOE Y，et al.
locally advanced non-small cell lung cancer：the NRG- The impact of metformin on tumor-infiltrated immune
LU001 phase 2 randomized clinical trial[J]. JAMA Oncol， cells：preclinical and clinical studies[J]. Int J Mol Sci，
2021，7（9）：1324-1332. 2023，24（17）：13353.
[46] LEE Y，JOO J，LEE Y J，et al. Randomized phase Ⅱ （收稿日期：2023-11-17 修回日期：2024-06-14）
study of platinum-based chemotherapy plus controlled （编辑：胡晓霖）

· 1922 · China Pharmacy 2024 Vol. 35 No. 15 中国药房 2024年第35卷第15期